The Brady Urological Institute, given through the generosity of James Buchanan Brady, opened January 21, 1915 and was the only one of its kind in the country.
Find a doctor
Learn about Urological conditions
Find Clinical Trials
The Brady Urological Institute, which opened in 1915, was the first urology residency in the United States. From its inception, this Institute has been dedicated to the training of academic urologists. We have well-developed programs in all aspects of adult and pediatric urology including robotics, reconstructive surgery, urological oncology, male infertility and sexual dysfunction, urodynamics, female urology, endourology, laparoscopy, and stone disease.
The Mission of Johns Hopkins School of Medicine is tripartite:
Teaching; Research & Patient Care.
As an academic teaching hospital, educating generations of medical professionals is essential to our institution.Read more
An opportunity to work directly with research faculty and clinicians using the most up-to-date clinical and research skillsRead more
Our residents primarily take academic positions and have had admirable success in achieving leadership positions.Read more
The Brady has been a leader in the study of Urologic diseases for over 100 years. Emphasis is placed on finding the causes of
diseases as well as developing new treatments to relieve the burden of illness on patients and their families.
Eugene Fuller Triennial Prostate Award
Dr. Carter, Professor of Urology and Oncology, is an internationally recognized expert in the diagnosis and treatment of prostate cancer.
Dr. Carter trained in urological surgery at The New York Hospital-Cornell Medical Center and completed a fellowship in urological oncology at the Brady Urological Institute at Johns Hopkins. In 1989, he joined the Johns Hopkins Medicine faculty as an assistant professor of urology, was promoted to associate professor in 1993, and full professor of urology and oncology in 1998.
Dr. Carter’s career has been focused on promoting a balanced approach to prostate cancer diagnosis and treatment. Although trained as a surgeon, he has been a voice of reason emphasizing the public health concerns of over diagnosis and over treatment of prostate cancer. Dr. Carter’s research interests and academic involvement have been directed toward reducing the harms of prostate cancer screening by improving screening practices. He led the American Urological Association Guideline Panel for the Diagnosis of Prostate Cancer that developed the first urological guidelines for prostate cancer screening. His development of a program in 1995 at Johns Hopkins to reduce the unnecessary treatment of localized prostate cancer has led to the acceptance of active surveillance as a standard of care approach to the management of favorable risk disease.
For his outstanding contributions in the field of prostate cancer, specifically in the areas of PSA screening and surveillance, Dr. Carter has been recognized by the American Urological Association with the Urology Care Foundation Distinguished Scholar Alumnus, the Distinguished Contribution Award, the Eugene Fuller Triennial Prostate Award, and the Huggins Medal from the Society of Urologic Oncology.
How your gift helps the Brady Urological Institute
Philanthropic support is critical to our continued success in the diagnosis and care of patients and the research that drives new treatments, new therapies and new surgical techniques.